Crimean-Congo Hemorrhagic Fever: A Growing Health Concern in Spain

Spanish health authorities have confirmed new cases of Crimean-Congo hemorrhagic fever (CCHF), prompting renewed warnings from medical experts about the disease's growing presence in the country. Once considered a rare and largely foreign illness, CCHF is now being described as an increasingly real threat within Spain.

The disease is primarily transmitted through the bite of infected ticks, small parasites commonly found on livestock and wild animals in rural environments. It can also spread through direct contact with the blood or bodily fluids of infected humans or animals, raising particular concern for farmers, veterinarians, and healthcare workers.

Experts have stressed that CCHF should no longer be regarded as something distant or exotic, given its confirmed presence in parts of Spain in recent years. The shift reflects broader patterns observed by scientists, who link the changing distribution of tick-borne diseases to factors such as climate change and the movement of animals across regions.

The virus responsible for the illness can cause a range of symptoms, from fever and muscle pain to, in more severe cases, internal bleeding. Health officials note that early diagnosis significantly improves patient outcomes, making public awareness of symptoms essential.

Authorities have issued guidance encouraging people to take preventive measures, particularly those spending time in rural or forested areas. Recommended precautions include wearing long clothing, using tick repellents, and carefully checking the skin after outdoor activity. Anyone who discovers a tick attached to their skin should remove it promptly and monitor for symptoms in the following days.

Public health agencies are continuing to monitor the epidemiological situation and have urged healthcare providers to remain alert for potential cases, especially among patients with a recent history of tick exposure or contact with animals in affected regions. Officials have emphasised that early detection and rapid medical response remain the most effective tools in managing the disease's impact.